Johnson & Johnson: American Transnational Pharmaceuticals Company

Johnson & Johnson Analysis

Johnson & Johnson is an American transnational pharmaceuticals company founded in 1886. J&J specializes in medical device production, goods manufacturing, and consumer packaging products. J&J is based in New Brunswick, New Jersey, with a secondary Consumer division based in Skillman, New Jersey. J&J possesses subsidiary companies spanning over two hundred fifty companies functioning throughout the span of fifty seven countries. Johnson & Johnson businesses and sales incorporate over one hundred seventy five countries and produce a whopping sales record of seventy four billion dollars in the year 2014.

Johnson & Johnson produces numerous items and brands ranging from first aid supplies to Tylenol medicines. Some products include Johnson baby products, Acuvue products, Band-Aid, and Neutrogena skin products. Some more popular brands would include Listerine, major over the counter medicines like Motrin, Sudafed, Benadryl, and even medical tobacco treatment products like Nicorette. Johnson & Johnson’s business stems primarily over three divisions, consumer products, medical devices, and pharmaceuticals.

Johnson & Johnson was founded by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson in New Brunswick, New Jersey, U.S.

The company started becoming an extreme catalyst in the development of healthcare in the 1800s. In the late 1800 Johnson & Johnson printed “Modern Methods of Antiseptic Wound Treatment” which rapidly became the U.S. standard texts for teaching antiseptic surgery. That print was just one of many products created by Johnson & Johnson that influenced vast advancements in healthcare. The first president of Johnson and Johnson was Robert Wood Johnson during the nineteenth century. Robert Johnson’s main inspiration was to improve sanitation practices and was succeeded in presidency by his brother James Wood Johnson after his death in

1910.
The Market Cap for Johnson & Johnson for Q1-14 was $264.84B. J&J possess 73% higher market cap than the next leading competitor. As of June 30, 2015 J&J possess a $257.33 billion dollar market capitalization. JNJ stock price currently is $93.31 with a (.41)% increase. Alex Gorsky is the Chief Executive Officer of JNJ. He became Chief Executive Officer on April 26, 2012. IBM drafted Gorsky as one of the board of directors for the company. Gorsky graduated from West Point in 1982 with a Bachelor of Science. He dedicated many years in various fields of business ranging from sales, marketing, and management roles at Janssen Pharmaceutica. Janssen Pharmaceutica is a JNJ unit based in New Jersey which is where he was able to be admitted into the company cooperation as Chief Operating Officer under the field of Head of General Medicines. Gorsky has assisted as the worldwide chairman of a particular group at JNJ called the Surgical Care Group based in Europe and Africa.
Johnson & Johnson is active in a multitude of sectors under Medical Devices, Consumer Health, and Pharmaceuticals. Some sectors include but are definitely not limited to: Orthopedics, Cardiovascular Disease, Coronary Artery Disease, Peripheral Vascular and Obstructive Disease, Diabetes Care, Insulin Delivery Devices, Urologic Surgeyr, Hernia Surgery, Baby Care, Skin & Hair Care, Over the Counter Medicines, Oral Health Care, and numerous more.
Pharmaceuticals portion of the company’s franchise is a major part of the company. Johnson & Johnson produce antibodies used in treatments of autoimmune diseases and other disease treatments. JNJ endured several product recalls on April 30, 2010. The company recalled 40 products including but not limited to Tylenol and Motrin. Several insufficiencies that did not meet value standards where discovered by an FDA inspection that lead to the recall. Since the April incident Johnson & Johnson has continued to have manufacturing issues which includes the recall of 9.3 million bottles of Tylenol due to mislabeling issues.